[144] ON24, Inc. SEC Filing
ON24, Inc. (ONTF) Form 144 notifies the proposed sale of 3,094 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $16,131.50, and an approximate sale date of 08/20/2025 on the NYSE. The filing states these shares were acquired as restricted stock from the issuer on 08/20/2025. The notice also discloses prior sales by the same account over May–June 2025 totaling 45,673 shares for gross proceeds of $253,233.97. The filer affirms no undisclosed material adverse information.
- Compliant disclosure: Filing provides required Rule 144 information including broker, number of shares, acquisition details, and seller attestations.
- Transaction detail: Acquisition characterized as restricted stock and broker details (Morgan Stanley Smith Barney LLC) are provided, improving transparency.
- Insider selling activity: The filer sold 45,673 shares in May–June 2025 for $253,233.97, which may concern investors monitoring insider dispositions.
- Relative concentration: Although the new proposed sale is small, recurring sales by the same account could be viewed negatively without further context about motives.
Insights
TL;DR: Routine insider sale notice; modest incremental sale relative to outstanding shares but notable recent selling activity.
The Form 144 reports a proposed sale of 3,094 common shares valued at $16,131.50 and shows the same account sold 45,673 shares in May–June 2025 for $253,233.97. With 42,306,290 shares outstanding reported in the filing, the proposed sale is immaterial on an absolute basis but the aggregated recent sales indicate ongoing disposition of holdings. Filing complies with Rule 144 disclosure requirements and includes acquisition details identifying the shares as restricted stock from the issuer.
TL;DR: Disclosure is complete for a Rule 144 notice; raises governance questions about insider liquidity but provides required representations.
The notice contains required seller representations and indicates the filer signed to confirm no undisclosed material adverse information. The form documents acquisition dates and nature (restricted stock) and lists broker details. While the filing is procedurally compliant, the pattern of multiple sales within a short timeframe may prompt stakeholder questions about insider liquidity choices or personal portfolio management, though no nonpublic information is asserted.